EPISODE · May 18, 2026 · 1 MIN
Bridging the Chasm in Ventricular Tachycardia: Medtronic’s Sphere-9 FDA Breakthrough Designation
from TheBrief.Health · host TheBrief.Health
Medtronic’s Sphere-9 catheter earned FDA Breakthrough status for ventricular tachycardia, combining RF and pulsed-field ablation to improve lesion durability, procedural safety, and recurrence outcomes significantly.
What this episode covers
Medtronic’s Sphere-9 catheter earned FDA Breakthrough status for ventricular tachycardia, combining RF and pulsed-field ablation to improve lesion durability, procedural safety, and recurrence outcomes significantly.
NOW PLAYING
Bridging the Chasm in Ventricular Tachycardia: Medtronic’s Sphere-9 FDA Breakthrough Designation
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m